IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.
about
Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cellsBrief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseNatural killer cells in infection and inflammation of the lungImmune responses and disease enhancement during respiratory syncytial virus infectionBiological challenges and technological opportunities for respiratory syncytial virus vaccine development.Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection.Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.Severe asthma in children.The bone marrow functions as the central site of proliferation for long-lived NK cells.Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthoodAlveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease developmentThe immune response to respiratory syncytial virus infection: friend or foe?Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner.NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice.Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung.Nasal vaccination induces protective immunity without immunopathology.Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.Pneumovirus and Metapneumovirus: Respiratory Syncytial Virus and Human Metapneumovirus
P2860
Q24681094-DED433B8-C659-4426-AD67-0353044307FEQ26775152-6C2646C9-479D-4EE5-96FB-FEA088B47ACFQ28391714-1B02CCED-1B1B-4C7E-9405-F5B9032D60A8Q33937152-FDA0C26B-035D-434A-A730-F25BC280964FQ34504791-A9B8CECA-5067-4E4B-A97F-4AA65D7FA698Q35217016-5C2A5E75-05B7-4EC4-92CE-5BF1C5A09C46Q35668961-8B14A4FA-C91D-4A72-9313-16B2E8F661D8Q35746966-D7F6B911-5EE5-4E6C-90B7-1239D050570CQ36108246-25615A01-6737-45AF-8BA7-CC7C2D193AABQ36187023-8AF48963-C824-4730-8770-79DA23A10D2AQ36371040-4331DFD9-1668-4C9D-B143-E669F3B24D49Q36540154-E050D3CF-7674-4D75-A11D-06CED15DE935Q36994294-F8B0C401-719B-458C-82B3-32B238FBCF5FQ37106159-9421CCE6-6446-4DA8-B166-3311B63910B8Q38333159-272753BB-03E5-4DD4-A3C7-D3FBDA1A9972Q40689054-1016E227-033A-4B52-98E6-0AFB36CE3A7CQ45422036-8C638EC9-4B0A-4975-8EDC-5B4F442A016BQ51696284-94D28186-435D-4A1B-9248-997BDBE8827DQ54548574-32F08D3D-4E0D-4A10-A06E-622995BF9919Q57987138-B95F0C9F-8226-4F0C-95B5-4D5571328DAA
P2860
IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@en
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@nl
type
label
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@en
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@nl
prefLabel
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@en
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@nl
P1476
IL-12-activated NK cells reduc ...... ll-immunodeficient conditions.
@en
P2093
Openshaw PJ
P304
P356
10.4049/JIMMUNOL.165.12.7109
P407
P577
2000-12-01T00:00:00Z